NOW AVAILABLE: For the Canadian and European MS Markets – A SnapShot analysis of promotional messaging and DTC initiatives for Q3, 2016.

Overall, 62 new pieces were distributed for the Canadian and European MS markets, a slight decrease from last quarter. Gilenya captured the highest volume with 24% of promotional materials in Q3, replacing Tysabri as the promotions leader. The main topics were new patient support programs (e.g. CoPACT), efficacy based on real-life clinical studies (e.g. ATTAIN), and the introduction of a new therapy, Zinbryta. Additional insights into marketing strategies and channel utilization are available in the full Q3 report.

Ex-US-Q3-2016-MS

About SnapShot

Helping to keep abreast of key competitor’s marketing strategies, CD Promo SnapShot is a quarterly competitive intelligence service of dtw Research, Inc. Snapshot reports provide an analytical view into the messaging and marketing tactics within specific therapeutic areas. The reports are sourced from dtw’s CD Promo WorldWide, the digitalized database of virtually all promotional materials distributed by the pharmaceutical industry since 1996. SnapShot reports include a detailed analysis of each brand’s messaging evolution, physician and DTC campaign initiatives, efficacy/comparative data, dosing, patient access, education and support programs, and more.

Reports are available by annual subscription for over 50 primary and specialty markets.

For more information please contact:

US Markets: Christine Alongi at Alongi@dtwresearch.com

Ex-US Markets: Robin Cefalo at Cefalo@dtwresearch.com